Skip to main content

Hot Flash Pills
vs
Oxybutynin for Hot Flashes

A side-by-side comparison of two menopause relief methods — efficacy, cost, how they work, and who shouldn't use them.

Side-by-side comparison

Method
Hot Flash Pills

Hot Flash Pills

A daily prescription pill (neurokinin receptor antagonist) that blocks NK3 receptors in the brain to reduce hot flashes and night sweats.

Oxybutynin for Hot Flashes

Oxybutynin for Hot Flashes

An off-label anticholinergic prescription (oxybutynin) that reduces sweating and hot flashes by acting on temperature pathways.

EfficacyRecommended see details

Recommended by the Menopause Society for symptom relief.

Recommended (limited evidence) see details

Recommended with limited evidence by the Menopause Society.

Cost$0–$780 /monthly

Insurance: Usually

$4–$30 /monthly

Insurance: Usually

DurationDaily pill (ongoing)Daily pill (ongoing)
ReversibilityReversibleReversible
STI ProtectionNoNo
How it works

Blocks neurokinin-3 (NK3) and/or neurokinin-1 (NK1) receptors in the hypothalamus to interrupt the temperature-regulation pathway that triggers hot flashes and night sweats.

Oxybutynin blocks acetylcholine receptors in the central nervous system, which may reduce sweating and hot flashes by acting on temperature regulation pathways.

PrescriptionRequired Prescription requiredRequired Prescription required
Available Products2 products1 product
Side effects
  • Elevated liver enzymes (requires monitoring)
  • Abdominal pain
  • Diarrhea
  • Insomnia
  • Back pain
  • Hot flush
  • Headache
  • Somnolence, dizziness, and fatigue (more common with dual NK1/NK3 antagonists)
  • Dry mouth (over 50% of users)
  • Constipation
  • Dizziness
  • Drowsiness
Who shouldn't use this
  • Cirrhosis or severe liver disease (NK3 antagonists such as fezolinetant)
  • Severe renal impairment or end-stage renal disease (NK3 antagonists such as fezolinetant)
  • Concomitant use of CYP1A2 inhibitors such as fluvoxamine or ciprofloxacin (NK3 antagonists such as fezolinetant)
  • Pregnancy (dual NK1/NK3 antagonists such as elinzanetant)
  • Glaucoma (narrow-angle)
  • Urinary retention
  • Gastric retention
  • Hypersensitivity to oxybutynin or any ingredient
  • Severe gastrointestinal disease (e.g., ulcerative colitis or toxic megacolon)